Lymphocyte activation gene-3 (LAG3), an important inhibitory immune checkpoint in tumor immunity, is expressed on activated CD4 + and CD8 + effector and exhausted T cells, natural killer (NK) cells, and B cells induced by T cells [3, 4]. This evidence concerns the gene CD8A and neoplasm.